Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Current and Projected Market Size of the Cough Hypersensitivity Syndrome Market Through 2034?
Recent years have witnessed a substantial increase in the market size for cough hypersensitivity syndrome. Projected to expand from a total worth of $10.36 billion in 2024 to $10.92 billion in 2025, it is set to experience a compound annual growth rate (CAGR) of 5.4%. The significant growth during the historic phase can be accredited to factors such as improved awareness, advancements in telemedicine and remote monitoring, public health campaigns, and an influx in research funding.
In the coming years, a significant surge is anticipated in the market size for cough hypersensitivity syndrome, escalating to$14.46 billion by 2029″ with a compound annual growth rate (CAGR) of 7.3%. The projected progression during the forecast period is associated with increased global health coverage, patient advocacy and support implementation, as well as enhancements in quality of life. The forecast period is expected to witness key trends such as enhancements in diagnostic and screening mechanisms, tailoring treatment strategies to individual patients, and the introduction of new medicines.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12989&type=smp
What Are the Core Growth Drivers Propelling the Cough Hypersensitivity Syndrome Market Forward?
The escalating occurrences of chronic respiratory diseases are predicted to fuel the expansion of the cough hypersensitivity syndrome market. Chronic respiratory diseases (CRDs) encompass a variety of enduring conditions that impact the airways and lungs, resulting in continuous breathing problems and deteriorating lung function over time. Therapy for cough hypersensitivity syndrome helps alleviate discomfort and promote respiratory health, thus enhancing the life quality for those diagnosed with chronic respiratory diseases such as asthma. As per the Australian Institute of Health and Welfare, a national agency based in Australia, nearly one-third (30%) of the Australian population, approximately 7.5 million people, were reported to have chronic respiratory diseases in June 2023. Additionally, data released by the National Center for Health Statistics (NCHS), a health statistics agency in the U.S., indicated that the rate of current asthma among adults aged 18 years and above in the U.S. rose from 8.4% in 2021 to 8.7% in 2022. The incidence of asthma episodes for adults in the respective age category also increased, moving from 3.3% in 2021 to 3.7% in 2022. Hence, the growing prevalence of chronic respiratory diseases is instrumental in propelling the cough hypersensitivity syndrome market forward.
What Segment Types Define the Cough Hypersensitivity Syndrome Market Structure?
The cough hypersensitivity syndromemarket covered in this report is segmented –
1) By Drug Class: Inhales Corticosteroids; Antitussive Agents; Short-acting Beta-2 Agonists; Anticholinergics; Proton Pump Inhibitors; Antihistamines; Other Drugs
2) By Route of Administration: Oral; Inhalation; Other Route Of Administration
3) By End-User: Hospitals; Specialty Clinics; Homecare; Other End-Users
Subsegments:
1) By Inhaled Corticosteroids: Budesonide; Fluticasone; Beclomethasone
2) By Antitussive Agents: Dextromethorphan; Codeine; Benzonatate
3) By Short-acting Beta-2 Agonists: Albuterol; Levalbuterol
4) By Anticholinergics: Ipratropium Bromide; Tiotropium
5) By Proton Pump Inhibitors: Omeprazole; Esomeprazole; Lansoprazole
6) By Antihistamines: Cetirizine; Loratadine; Diphenhydramine
7) By Other Drugs: Mucolytics; Combination Therapy Drugs
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=12989&type=smp
Which Geographic Areas Hold the Strongest Growth Potential in the Cough Hypersensitivity Syndrome Market?
North America was the largest region in the cough hypersensitivity syndrome market in 2024. The regions covered in cough hypersensitivity syndrome market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Which Emerging Trends that Are Influencing theCough Hypersensitivity Syndrome Industry Evolution?
Leading firms in the cough hypersensitivity syndrome market are prioritizing the development of asthma treatment options such as asthma rescue inhalers to enhance patient results and overall life quality. Asthma rescue inhalers, which are compact, quick-acting medicine dispersing apparatus, can provide swift relief from sudden cough fits by instantly lessening airway sensitivity and relieving cough-induced airway blockages. For example, in April 2024, Teva Pharmaceutical Industries Ltd., a pharmaceutical firm based in Israel, entered a partnership with Launch Therapeutics, a clinical development corporation from the US. This collaboration seeks to hasten the clinical research process for its ICS-SABA (inhaled corticosteroid and short-acting beta-agonist) inhaler, namely TEV-‘248. This inhaler integrates both fluticasone propionate and albuterol sulfate targeting both adult and pediatric asthma patient demographics. Moreover, it aspires to lower the dependency on generic medicines.
View the full report here:
What Is the Definition of the Cough Hypersensitivity Syndrome Market?
Cough hypersensitivity syndrome (CHS) is a medical condition characterized by an exaggerated and abnormal response of the cough reflex to various stimuli, often leading to persistent and chronic coughing. It is commonly associated with conditions such as asthma, gastroesophageal reflux disease (GERD) and upper airway disorders.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12989
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model